Santhera Pharmaceuticals Holding AG Logo

Santhera Pharmaceuticals Holding AG

ISIN: CH0027148649 | Ticker: SANN

About Santhera Pharmaceuticals Holding AG

Company Description

We are focusing on the development of treatments for neuromuscular and pulmonary diseases that currently lack treatment options, such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF).
We have dedicated more than a decade to researching potential treatments in our ongoing mission to make effective medicines available for these often overlooked, life-altering diseases. We are passionate about improving patients’ quality of life and our vision is to be a leader in providing treatments for rare diseases in these areas with high unmet medical needs.

Year founded

2004

Served area

Worldwide

Headcount

91

Headquarters

Hohenrainstrasse 24, 4133 Pratteln – Switzerland

Shareholder information

Shares outstanding

73,721,374

IPO

Nov. 3, 2006

Stock exchange(s)

SIX Swiss Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.